ABSTRACT
B
rain growth is an important predictor of neurodevelopmental outcome in preterm infants. [1] [2] [3] [4] In neonatal intensive care units (NICUs), brain growth is usually monitored by manual measurement of head circumference. However, head circumference measurement has a low interrater agreement and does not correspond well with actual brain development. 5, 6 Therefore, there is a need for a new reliable bedside marker for monitoring preterm brain growth in clinical practice.
Brain structures measured by cranial ultrasound (CUS) could provide clinically applicable markers for brain growth. A few sonographic markers of brain growth have been used in the past, mainly measuring the corpus callosum (CC) or cerebellum, thereby reflecting growth of a small part of the brain only. [7] [8] [9] [10] [11] In addition to currently available markers of preterm brain development, we propose that the length between the genu of the CC and the fastigium (roof of the fourth ventricle) could serve as a new marker for brain growth. The aim of this study was to evaluate the usefulness of corpus callosum-fastigium (CCF) length and CC length, an existing marker, as markers for monitoring brain growth in preterm infants during the NICU stay. We assessed the reproducibility of CC and CCF length measurements, developed growth charts for preterm infants between 24 and 32 weeks of gestation, and evaluated prenatal and postnatal characteristics possibly associated with CC and CCF growth trajectories. We hypothesized that both measurements are highly reproducible. Furthermore, we hypothesized that CCF and CC growth trajectories are associated with prenatal and postnatal determinants of neurodevelopmental outcome in preterm infants.
MATERIALS AND METHODS
This prospective observational cohort study was performed at the level III NICU of the Sophia Children's Hospital, Erasmus MC, Rotterdam, the Netherlands. The local medical ethics review board approved this study. Written parental consent was obtained before participation. Between 2010 and 2012, all newly admitted singleton, preterm infants born before 29 weeks' gestational age (GA) were eligible for enrollment. We applied the following exclusion criteria: 1) unknown GA at birth; 2) major congenital abnormalities, and 3) extensive brain injury (including intraventricular hemorrhage grade III, posthemorrhagic ventricular dilation, and venous infarction). The latter complications are expected to influence the validity of the measurements due to possible midline shift and expected altered brain growth. GA at birth was dated by using the first day of the last menstrual period and was confirmed by first trimester crown rump length measurement on sonography. Postnatal age was expressed by postmenstrual age, calculated as GA at birth ϩ weeks and days of postnatal age. Pregnancy and neonatal characteristics were collected prospectively. Maternal characteristics were collected retrospectively from medical records. Pregnancy complications, including intrauterine growth retardation and pre-eclampsia and hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome were obtained from obstetric records and were defined on the basis of clinical definitions according to national guidelines.
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Cranial Sonography and Measurements
CUS was performed according to the standard local protocol on the day of birth; on days 1, 2, 3, and 7 of life; and then weekly until discharge. The protocol was only disregarded on clinical grounds (eg, hemodynamic instability). One researcher (M.M.A.R.) performed all CUS by using a MyLab 70 scanner (Esaote, Genoa, Italy), with a convex neonatal probe (7.5 MHz) . Measurements were performed off-line by using the Mylab software (Esaote). Measurements of CC and CCF length were performed on a standard sagittal plane. In this plane, a complete corpus callosum (genu to the splenium) and distinct vermis of the cerebellum, including the fastigium, had to be visualized. CCF length was measured from the genu of the corpus callosum (outer border) to the fastigium. CC length was measured from outer to outer border (genu to the splenium, Fig 1) . All measurements were performed by 1 investigator (M.M.A.R.). To establish the reliability, a second investigator (J.A.R), blinded to the previous results, measured 30 randomly selected scans of varying quality and of neonates with different GAs.
Statistical Methods
Data were analyzed by using SPSS (Release 21 for Windows; IBM, Armonk, New York) and R statistical and computing software (http://www.r-project.org/). P values Ͻ .05 were statistically significant. Median value and interquartile range and means and SDs were used as appropriate.
Intraobserver and interobserver agreements for CC and CCF lengths were evaluated by using the intraclass correlation coefficient and Bland-Altman plots. 13 The intraclass correlation coefficient was analyzed by using a 2-way mixed model. Cutoff values were in accordance with Landis and Koch.
14 Growth charts were developed for CCF and CC growth as a function of postmenstrual age (weeks) and weight (grams). To model the relation between the measured CCF and CC lengths and a predefined list of covariates, we estimated linear mixed models by using lme (in the R nlme package; http://www.inside-r.org/r-doc/nlme/ lme). 15 To account for the within-subject correlation, we used a random intercept and random coefficient of GA and a power variance function to model the residual covariance. The predefined covariates were GA at birth, birth weight (BW) SD score, sex, intrauterine growth retardation (defined as estimated fetal weight below 10th percentile), pre-eclampsia/ HELLP, chorioamnionitis, death, sepsis, and days on mechanical ventilation. In all models, both GA and GA 2 (square of GA) were used as covariates. The additional predictors were added to this basic model separately (termed "univariable models" below) and all at once (the multivariable model).
RESULTS
Of 336 neonates admitted to our NICU during the study period, 152 were eligible for inclusion. Twelve neonates were excluded because they met the exclusion criterion of extensive brain injury, resulting in a sample size of 140 neonates. Baseline maternal and neonatal characteristics are listed in Table 1 . The median gestational age at birth was 27 ϩ2 weeks (interquartile range, 26 ϩ1 -28 ϩ1 ); the median birth weight was 955 g (interquartile range,
-1125 g
). The number of sonography scans per neonate ranged from 1 to 8.
Reproducibility
The mean interobserver difference was Ϫ0.3207 Ϯ 1.4527 mm for CCF (P ϭ .244) and 0.4600 Ϯ 1.8463 mm for CC length (P ϭ .183). The ICCs for interobserver and intraobserver analysis showed excellent agreement for both CCF and CC length (respectively, intraobserver: 0.958; 95% CI, 0.912-0.980; interobserver: 0.885; 95% CI, 0.770 -0.944; and intraobserver: 0.922; 95% CI, 0.844 -0.962; and interobserver: 0.893; 95% CI, 0.783-0.948). Figure 2 shows Bland-Altman plots of interobserver and intraobserver agreement for both measurements.
CC and CCF Length
The mean CCF length was 40.9 Ϯ 2.97 mm, with a range from 34.0 to 54.3 mm. The mean CC length was 36.3 Ϯ 3.33 mm, with a range from 26.6 to 48.8 mm. Growth charts of CCF and CC lengths by postmenstrual age and by weight are shown in Fig 3. 
Linear Mixed Models
Results of univariable analyses are shown in Table 2 for CC and CCF growth. The multivariable analysis confirmed a positive association between the BW SD score and the CCF growth rate and a negative association between female sex and the CCF growth rate. For the CC growth rate, a positive association was found with the BW SD score by using multivariable analysis.
DISCUSSION
In this report, we demonstrated that CCF length, measured by using CUS, is a reproducible and feasible marker that could serve as a new bedside tool to monitor preterm infant brain growth during the NICU stay. We provided growth charts of CCF and CC length for preterm infants from 24 to 32 weeks' postmenstrual age. We found that a higher BW SD score results in an increased CCF and CC growth rate during the hospital stay, while female infants have a slower CCF growth compared with male infants.
Previous sonography studies have evaluated only a limited number of brain structures as potential markers for brain growth or predictors for neurodevelopmental outcome in preterm infants. [7] [8] [9] [10] One explanation for this is that the brain has few easily recognizable and consistent landmarks for reliable measurements on CUS. The CC, a flat bundle of white matter that connects the left and right hemispheres, is one of the brain structures that is easily visualized and recognizable on CUS. 16 Prematurity is known to affect CC development, by the early transition from intrauterine to extrauterine life and by postnatal stress and injury, 17 leading to both structural and functional impairment. 18, 19 Associations have been found between the length and thickness of the CC and brain volumes and neurodevelopmental outcome. 11, 20, 21 Further studies should elucidate whether CC length can be considered a proxy of telencephalon development, creating an impression of white matter development and brain maturation. The advantages of using CCF length in the monitoring of brain growth rely on anatomic and practical issues. CCF length may be considered a marker of diencephalon and mesencephalon development and vermis growth. The diencephalon includes the thalamus, a neural relay center crucial for adequate cogni- tive function. 22 Altered development of the thalamus, and thus of the diencephalon, may lead to adverse neurodevelopmental outcome. Several studies showed impaired thalamus volume and extreme vulnerability of the thalamus to be neonatal risk factors after preterm birth. 23, 24 Whether thalamic injury or growth impairment directly influences CCF length needs to be further studied.
One of the other advantages of CCF length measurement is the use of CUS instead of MR imaging or head circumference measurements. In Table 3 , the pros and cons of every method are depicted. Although volumetric MR imaging is increasingly used for growth assessment of the preterm brain, its use for serial assessment is still very limited. 2 Head circumference measurement has a low interrater agreement and limited association with longterm outcome and does not measure actual brain growth, but growth of the skull and the subarachnoid spaces, which are frequently enlarged in preterm infants. 5, 6, 25 Measurement of CCF length is not considered a burden compared with head circumference measurement because it can be performed on routine CUS, which is often recommended weekly in preterm infants. 26 Both CCF length and CC length can already be measured prenatally because the CC and the fastigium are visible on sonography at around 18 weeks of gestation; this feature allows the use of the same marker prenatally and postnatally for monitoring of brain growth. 27 In accordance with previous studies, we showed satisfactory reproducibility for CC length. 7 CCF reproducibility was excellent too; this finding suggests that both measurements are feasible for longitudinal evaluation of brain growth. Increasing lengths with increasing ages and weights, as shown in the growth charts, support the use of these markers in clinical practice.
We observed a nonlinear growth pattern for CC and CCF length. Previous studies found an intrauterine constant growth rate of 0.20 -0.22 mm/day of the CC. 28, 29 Also in preterm infants, a constant-though-slower growth rate was observed. 7 In contrast to previous studies, we performed longitudinal measurements (1-8 scans per infant), allowing a more reliable estimation of CC growth. Other brain structures, such as the vermis of the cerebellum, show a nonlinear growth pattern as well. 8 Because we are the first to evaluate the use of CCF length, no literature is available for comparison, to our knowledge. We did expect a nonlinear growth pattern based on current literature.
In Fig 3, parts of the weight charts are gray because we advise not using these parts as a reference curve. We chose to analyze and present the complete original data of infants with a postmenstrual age between 24 and 32 weeks and not to select ideal reference cases. The drawback is seen in the upper part of the weight charts; the curves appear to go down above 1400 g and, despite the very small numbers, the confidence interval narrows. This finding, of course, does not reflect an incline of brain size, but rather selection and censoring. These data are not "first measurements" (reflecting intrauterine accomplished growth) but are follow-up data of patients with prolonged NICU admission, representing the most complex cases (eg, with severe chronic lung disease) not stable enough to be discharged early. In conclusion, the last part of this curve depicts valid data that you would expect in a NICU population, but we consider these not representative of normal growth in preterm infants.
The decreased growth rate of the CCF length in female infants is in accordance with previous studies, which identified sex differences in brain structures and neurodevelopmental outcome. 30, 31 The positive association between BW SD score and CCF and CC growth rate is also in accordance with current literature. 32 One investigator who was trained in visualizing a standard sagittal plane performed all the scans. This likely improved the quality of the scans and may have enhanced the reproducibility. We realize, therefore, that the clinical applicability is probably overestimated in our cohort. Reliable measurements and a correct sagittal plane by using CUS depend on the experience of the observer but are easy to learn. Recently developed software to identify the sagittal plane automatically may further increase the reproducibility and clinical applicability. 33 This study has some limitations. First, in the Netherlands, preterm neonates are transferred to a secondary hospital relatively early, accounting for very little data in our cohort of infants born at 29 weeks' gestation and limited data of infants after 30 weeks' gestation. Although white matter injury is already visible on scans after a few days, brain atrophy is often only noticeable after weeks to months. 34 Our short follow-up time could explain why we did not find an association between expected clinical variables, such as sepsis and days on mechanical ventilation, and CCF or CC growth rate. Second, including all scans between 24 and 32 weeks' postmenstrual age may have influenced the reliability of the growth charts; that preterm infants lose weight after birth and start to grow days later is a common finding. Brain growth may be limited before regaining birth weight (usually after 10 days). This limitation may have increased variation in CC and CCF lengths. Extremely preterm and clinically unstable infants have longer NICU stays and are likely to undergo more CUS. This feature might have biased our growth charts. On the other hand, our data reflect clinical practice in a neonatal intensive care setting.
In future studies, it would be interesting to compare fetal and preterm CCF growth. Currently, we are scanning fetuses in the second and third trimesters of pregnancy to develop reference curves for fetal brain growth, which could also serve as an ideal growth curve for preterm neonates. We were not yet able to assess the association between feeding regimens and growth during the NICU stay and CCF growth trajectories. This is of interest because it may have clinical implications for nutritional practices. Moreover, CCF length can possibly be used as an outcome measure in nutritional and other intervention studies. It would be of main interest to assess whether CCF length, possibly combined with other available markers of brain growth such as CC length, could serve as a predictor of neurodevelopmental outcome. The clinical applicability may extend beyond the NICU stay into the outpatient follow-up period because the anterior fontanelle can be used as an acoustic window until approximately 6 months in most infants.
CONCLUSIONS
There is a lack of bedside markers for brain growth in preterm infants during the NICU stay. We propose a feasible, new sonography measurement called "corpus callosum-fastigium length" with high reproducibility for monitoring brain growth in preterm infants during the hospital stay. This marker may help clinicians determine whether preterm infants show adequate postnatal brain growth and may eventually be used as an outcome measure in nutritional and other intervention studies. Further research is warranted to assess whether this marker could also serve as an early predictor for short-term and long-term neurodevelopmental outcome. Note:-ϩϩ indicates very good; ϩ, acceptable; Ϫ, bad agreement with the corresponding item; Ϯ, mediocre; HC, head circumference.
